One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: The e-BioMatrix multicenter post marketing surveillance registry in India

OBJECTIVE: The e-BioMatrix is a post marketing multicenter registry with an objective to evaluate the 2 year clinical safety and efficacy outcomes in patients treated with BioMatrix™ - Biolimus A9™ (BA9™) drug eluting stents (DES). BACKGROUND: Drug-eluting stents still have late-stage disadvantages...

詳細記述

保存先:
書誌詳細
主要な著者: Mehta, Ashwin B., Chandra, Praveen, Dalal, Jamshed, Shetty, Prabhakar, Desai, Devang, Chocklingam, K., Prajapati, Jayesh, Kumar, Pramod, Magarkar, Vilas, Vasawada, Apurva, Goyal, B.K., Kumar, Viveka, Rao, V. Suryaprakash, Babu, Ramesh, Parikh, Pritesh, Kaul, Upendra, Patil, Aruna, Mhetre, Tushar, Rangnekar, Hrishikesh
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2013
主題:
Sponsored Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3860730/
https://ncbi.nlm.nih.gov/pubmed/24206883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2013.08.031
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料